News

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

22 February, 2023

21 February, 2023

17 February, 2023

16 February, 2023

14 February, 2023

14 February, 2023

Pokaż więcej ↓

Pokaż mniej ↑

News

Opinion of the Transparency Council – amendments to the drug programme B.47

Opinion of the Transparency Council – stiripentol

Opinion of the Transparency Council – amendments to the drug programme B.90

Position of the Transparency Council – Apexxnar

Position of the Transparency Councii – Lorviqua (lorlatinib)

Opinion of the Transparency Council – venlafaxine

Opinion of the Transparency Council – metformin

Opinion of the Transparency Council – chloroquine

Position of the Transparency Council – Keytruda (pembrolizumab) eTNBC

Position of the Transparency Council – Keytruda (pembrolizumab) mTNBC

Position of the Transparency Council – Beovu (brolucizumab)

Position of the Transparency Councii – Ofev (nintedanib)

Position of the Transparency Council – Brukinsa (zanubrutinib)

Opinion of the Transparency Council – health policy pof the City of Opole in the field of early detection of hearing and vision impairment in children

Opinion of the Transparency Council – M-TYPER

Position of the Transparency Council – Verzenios (abemaciclib)

Position of the Transparency Council – Libtayo (cemiplimab)

Position of the Transparency Council – Reducto spezial (potassium dihydrogen phosphate, sodium monohydrogen phosphate)

Position of the Transparency Council – Fostex Nexthaler (beclometasone dipropionate) anhydrous + formoterol fumarate dihydrate

The Transparency Council meeting 9/2023 on 27 February 2023

Communication – Data acquisition: adrenal scintigraphy/other body areas

Meeting of the Transparency Council 8/2023 on 20 February 2023 – UPDATE

The Meeting of the Tariffs Council No. 5/2023 of 23.02.2023

Communication – Data acquisition: Palliative and hospice care